p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cells
Luciana P. Rangel(Universidade Federal do Rio de Janeiro), Jerson L. Silva(National Institute of Science and Technology for Structural Biology and Bioimaging), Sarah M.M.V. Andrade(Universidade Federal do Rio de Janeiro), Caroline L. Costa(Universidade Federal do Rio de Janeiro), Danielly C. Ferraz da Costa(National Institute of Science and Technology for Structural Biology and Bioimaging), Giulia D. S. Ferretti(Medical University of South Carolina), Renato S. Carvalho(Instituto Nacional do Câncer)
Cited by 86
Related Papers
Ligand Binding and Hydration in Protein Misfolding: Insights from Studies of Prion and p53 Tumor Suppressor Proteins
|Accounts of Chemical Research|2009|110
Phase separation of p53 precedes aggregation and is affected by oncogenic mutations and ligands
|Chemical Science|2021|108
Oncogenic Gain of Function in Glioblastoma Is Linked to Mutant p53 Amyloid Oligomers
|iScience|2020|82
Targeting Biomolecular Condensation and Protein Aggregation against Cancer
|Chemical Reviews|2023|78
Anticancer Potential of Resveratrol, β-Lapachone and Their Analogues
|Molecules|2020|66